Salvianolic acid B inhibits the proliferation and metastasis of A549 lung cancer cells via miR-23a/PTEN/AKT pathway
Ye Yang, Lei Huang, Li Dai, Xin Zhou, Bingjun Qian · 2025
Read Salvianolic acid B inhibits the proliferation and metastasis of A549 lung cancer cells via miR-23a/PTEN/AKT pathway by Ye Yang, Lei Huang, Li Dai, Xin Zhou, Bingjun Qian (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12748603.txt.
Description
Ye Yang and co-authors test a plant compound against lung cancer cells in the lab and in mice. Their 2025 paper studies salvianolic acid B, a compound from a traditional herb, with known anti-cancer promise. They use the A549 lung cancer cell line as their test system.
Cells dosed with the compound grew, moved, and invaded less as the dose rose. In mice, tumors treated with the compound grew and spread less as well. Tests pointed to a pathway in which the compound raises a tumor-blocking gene through a small RNA switch, which then calms a growth signal. Marker shifts in the treated cells fit that story. The work is early, cell and animal level evidence, but it names a clear route for follow-up drug study.
Catalog record
| CREATOR | Ye Yang, Lei Huang, Li Dai, Xin Zhou, Bingjun Qian |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |